<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04614649</url>
  </required_header>
  <id_info>
    <org_study_id>RIFT-TR</org_study_id>
    <nct_id>NCT04614649</nct_id>
  </id_info>
  <brief_title>Right Iliac Fossa Treatment-Turkey Audit</brief_title>
  <acronym>RIFT-Turkey</acronym>
  <official_title>Right Iliac Fossa Treatment-Turkey Audit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: There is significant variation in the management of patients with right iliac&#xD;
      fossa (RIF) pain. Whilst laparoscopy has become first line in many units, the 2012 UK&#xD;
      National Appendicitis Audit identified that a third of appendicectomies at that time were&#xD;
      being performed using an open approach1. The results of this study were widely presented at&#xD;
      local units and national meetings as well as being published in several journals.&#xD;
&#xD;
      New Guidelines: New guidelines published by the World Society of Emergency Surgery (WSES) in&#xD;
      20165 and the European Association of Endoscopic Surgeons (EAES) in 20156 provide an&#xD;
      opportunity to close the loop on the 2012 audit and to re-audit the modern management of RIF&#xD;
      pain.&#xD;
&#xD;
      Aim: The primary audit aim is to determine the laparoscopic appendicectomy rate in 2017.&#xD;
&#xD;
      The secondary aim is to audit the normal appendicectomy rate. Variation in centres' case mix&#xD;
      may influence the normal appendicectomy rate. Patients can be stratified into low, medium,&#xD;
      and high risk for appendicitis using the Alvarado or Appendicitis Inflammatory Response (AIR)&#xD;
      scores (see Appendix E). Baseline variation will be addressed by adjustment using risk&#xD;
      scoring.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Audit standarts:&#xD;
&#xD;
        1. An initial laparoscopic approach should be used for appendicectomy unless&#xD;
           contraindicated.This standard is based on WSES Statement 5.15-7&#xD;
&#xD;
        2. The normal appendicectomy rate should be &lt;20%1. For centres with higher or lower rates,&#xD;
           risk stratification data will allow interpretation of this rate in relation to the&#xD;
           baseline case-mix.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>The Rate of Laparoscopic Appendicectomy.</measure>
    <time_frame>30 days from operation</time_frame>
    <description>The primary outcome measure is the rate of laparoscopic appendicectomy. The audit standard is provided by the World Society of Emergency Surgery's Jerusalem Consensus Guidelines which states that &quot;laparoscopic appendectomy should represent the first choice where laparoscopic equipment and skills are available, since it offers clear advantages in terms of less pain, lower incidence of surgical site infection, decreased length of stay, earlier return to work and overall costs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Normal Appendicectomy Rate</measure>
    <time_frame>30 days from operation</time_frame>
    <description>The secondary outcome measure will be the normal appendicectomy rate.The National Appendicectomy Audit reported the rate as 20.6% for the UK1. Centres should have a normal appendicectomy rate &lt;20%. Risk stratification data using Alvarado/ AIR score will allow interpretation of individual centres' rates in light of their baseline casemix.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Right Iliac Fossa Pain</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred to general surgeons, or pediatric general surgeons, with undifferentiated&#xD;
        right iliac fossa pain or suspected appendicitis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients referred to general surgeons, or pediatric general surgeons,&#xD;
             with undifferentiated right iliac fossa pain or suspected appendicitis.&#xD;
&#xD;
          -  All patients who undergo an appendicectomy during the study period.&#xD;
&#xD;
          -  Age restriction is existing; all patients over the age of 16 should be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous appendicectomy, right hemi-colectomy or total colectomy.&#xD;
&#xD;
          -  Previous abdominal surgery in the last 90 days.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Patiens confirmed with COVID-19.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sezai Leventoglu, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Yalcinkaya, Dr</last_name>
    <phone>(+90)5334254560</phone>
    <email>ali.yalcinkaya@gazi.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gulsum Sueda Kayacan, Dr</last_name>
    <phone>+905066932403</phone>
    <email>gulsum.sueda.kayacan@gazi.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <zip>06560</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Yalcinkaya, Dr</last_name>
      <phone>+905334254560</phone>
      <email>aliyalcink@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gulsum Sueda Kayacan, Dr</last_name>
      <phone>+905066932403</phone>
      <email>gulsum.sueda.kayacan@gazi.edu.tr</email>
    </contact_backup>
    <investigator>
      <last_name>Sezai Leventoglu, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 29, 2020</study_first_submitted>
  <study_first_submitted_qc>October 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>October 29, 2020</last_update_submitted>
  <last_update_submitted_qc>October 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Ali Yalcinkaya</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Derived anonymised data at the patient-level may be able to be made available for sharing</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Following publication of the main results</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

